Xylem Inc.
XYL
$128.96
-$0.71-0.55%
Weiss Ratings | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Good | |||
Risk Index | Fair | |||
Risk Grade | C | |||
Reward Grade | B | |||
Rating Factors | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Weak | |||
Growth Index | Excellent | |||
Efficiency Index | Good | |||
Solvency Index | Excellent | |||
Total Return Index | Fair | |||
Volatility Index | Fair | |||
Beta / Standard Deviation | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.19 | |||
Price History | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 0.70% | |||
30-Day Total Return | 6.35% | |||
60-Day Total Return | 2.48% | |||
90-Day Total Return | -1.51% | |||
Year to Date Total Return | 11.57% | |||
1-Year Total Return | 3.21% | |||
2-Year Total Return | 27.52% | |||
3-Year Total Return | 60.44% | |||
5-Year Total Return | 68.50% | |||
52-Week High % Change | -11.23% | |||
52-Week Low % Change | 14.49% | |||
Price | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $146.08 | |||
52-Week Low Price | $113.26 | |||
52-Week Low Price (Date) | Jan 13, 2025 | |||
52-Week High Price (Date) | May 21, 2024 | |||
Valuation | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 31.52B | |||
Enterprise Value | 33.08B | |||
Price/Earnings (TTM) | 35.53 | |||
Earnings Per Share (TTM) | 3.65 | |||
Earnings Per Share Growth | 34.37% | |||
Price/Earnings To Growth | 1.03 | |||
Price/Sales (TTM) | 3.69 | |||
Price/Book (Q) | 2.96 | |||
Enterprise Value/Revenue (TTM) | 3.86 | |||
Price | $128.96 | |||
Enterprise Value/EBITDA (TTM) | 19.65 | |||
Enterprise Value/EBIT | 29.51 | |||
Market Cap Category | Large Cap | |||
Dividends and Shares | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 243.77M | |||
Dividend Yield | 1.14% | |||
Div. Per Share (Most Recent) | $0.40 | |||
Dividend Per Share (TTM) | $1.48 | |||
Payout Ratio (TTM) | 39.33% | |||
Dividend Per Share (Most Recent) | $0.40 | |||
Company Info | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 202 869 9150 | |||
Address | 300 Water Street SE Washington, DC 20003 | |||
Website | www.xylem.com | |||
Country | United States | |||
Year Founded | 2011 | |||
Profitability | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 13.09% | |||
Profit Margin | 10.39% | |||
Management Effectiveness | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 4.30% | |||
Return on Equity | 8.45% | |||
Income Statement | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 8.56B | |||
Total Revenue (TTM) | 8.56B | |||
Revenue Per Share | $35.12 | |||
Gross Profit (TTM) | 3.21B | |||
EBITDA (TTM) | 1.68B | |||
EBIT (TTM) | 1.12B | |||
Net Income (TTM) | 890.00M | |||
Net Income Avl. to Common (TTM) | 890.00M | |||
Total Revenue Growth (Q YOY) | 6.52% | |||
Earnings Growth (Q YOY) | 22.56% | |||
EPS Diluted (TTM) | 3.65 | |||
EPS Diluted Growth (Q YOY) | 21.05% | |||
Balance Sheet | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 1.12B | |||
Cash Per Share (Q) | $4.60 | |||
Total Current Assets (Q) | 4.10B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 10.88B | |||
Current Ratio (Q) | 1.754 | |||
Book Value Per Share (Q) | $43.80 | |||
Total Assets (Q) | 16.49B | |||
Total Current Liabilities (Q) | 2.34B | |||
Total Debt (Q) | 2.44B | |||
Total Liabilities (Q) | 5.61B | |||
Total Common Equity (Q) | 10.64B | |||
Cash Flow | XYL - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -482.00M | |||
Cash from Financing (TTM) | -615.00M | |||
Net Change in Cash (TTM) | 102.00M | |||
Levered Free Cash Flow (TTM) | 964.13M | |||
Cash from Operations (TTM) | 1.26B | |||